关注
John Power
John Power
在 health.ucsd.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Electrocardiographic manifestations of immune checkpoint inhibitor myocarditis
JR Power, J Alexandre, A Choudhary, B Ozbay, S Hayek, A Asnani, ...
Circulation 144 (18), 1521-1523, 2021
592021
State-of-the-art of endomyocardial biopsy on acute myocarditis and chronic inflammatory cardiomyopathy
E Ammirati, A Buono, F Moroni, L Gigli, JR Power, M Ciabatti, A Garascia, ...
Current cardiology reports 24 (5), 597-609, 2022
492022
Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis
LH Lehmann, MB Heckmann, G Bailly, D Finke, A Procureur, JR Power, ...
Circulation 148 (6), 473-486, 2023
262023
Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations
JR Power, LK Keyt, ED Adler
Expert review of cardiovascular therapy 20 (4), 241-251, 2022
232022
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ...
Nature Medicine 29 (12), 3100-3110, 2023
122023
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
J Nowatzke, P Guedeney, N Palaskas, L Lehmann, S Ederhy, H Zhu, ...
European Journal of Cancer 177, 197-205, 2022
122022
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
JR Power, J Alexandre, A Choudhary, B Ozbay, SS Hayek, A Asnani, ...
Archives of cardiovascular diseases 115 (5), 315-330, 2022
102022
Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation
KR Nakazawa, SP Wengerter, JR Power, RA Lookstein, RO Tadros, ...
Journal of Vascular Surgery 66 (1), 151-159, 2017
102017
Trends in vena cava filter insertions and “prophylactic” use
JR Power, KR Nakazawa, AG Vouyouka, PL Faries, NN Egorova
Journal of Vascular Surgery: Venous and Lymphatic Disorders 6 (5), 592-598. e6, 2018
82018
The impact of surgical care improvement project measures on in-hospital outcomes following elective vascular procedures
KR Nakazawa, NN Egorova, JR Power, PL Faries, AG Vouyouka
Annals of Vascular Surgery 38, 17-28, 2017
82017
Strengthening value-based medication management in a free clinic for the uninsured: Quality interventions aimed at reducing costs and enhancing adherence
RK Arao, YOC Michelle, T Barrett, L Chockalingam, F Khan, A Kumar, ...
BMJ open quality 6 (2), e000069, 2017
72017
Reconstruction of “unreconstructable” critical limb ischemia with hybrid techniques
JR Power, C Chung, PS Lajos, PL Faries, ML Marin, RO Tadros
Journal of Vascular Surgery Cases 2 (1), 10-13, 2016
52016
Vascular medicine and cardio-oncology–A new, evolving clinical frontier
J Versmissen, JR Power, J Moslehi
Vascular Medicine 25 (3), 205-207, 2020
42020
Predictors of steroid-refractory immune checkpoint inhibitor associated myocarditis
J Power, W Meijers, C Fenioux, Y Tamura, A Asnani, J Alexandre, ...
European Heart Journal 41 (Supplement_2), ehaa946. 3272, 2020
32020
Femoral access for iliac branched endoprosthesis deployment in patients with a prior bifurcated aortic stent graft
RO Tadros, JR Power, SP Wengerter, CYM Png, ML Marin, PL Faries, ...
Annals of Vascular Surgery 53, 262-265, 2018
32018
PC038. Influence of Infrarenal Oversizing of Aortic Stent Grafts on Patient Outcomes
WE Beckerman, RO Tadros, A Sher, JR Power, CYM Png, M Tardiff, ...
Journal of Vascular Surgery 63 (6), 164S, 2016
12016
PO-01-137 ECG AND CT CHARACTERISTICS OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS SUCCESSFULLY ABLATED AT THE ANTERIOR CORONARY SINUS OS
J Power, JC Hsu, FT Han, KS Hoffmayer, F Raissi, DE Krummen, GK Feld, ...
Heart Rhythm 21 (5), S145-S146, 2024
2024
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023)
C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ...
NATURE MEDICINE, 2024
2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ...
Nature Medicine, 1-1, 2024
2024
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
JR Power, C Dolladille, A Procureur, SR Ederhy, NL Palaskas, ...
medRxiv, 2024.06. 02.24308336, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20